Abstract
Although advances in knowledge of the genesis and progression of cancer, and development of new antitumor drugs, mortality rates by this disease are still quite high. Thus, the application of new drugs as main or adjuvant in cancer treatment have been studied over the years, though none of these drugs had reached significant success in clinical evaluations until now. Therefore, the search…